HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Acute alcoholic liver disease — Clinical Guidelines

Overview

Alcoholic liver disease (ALD) encompasses a spectrum of liver conditions from simple steatosis to severe alcoholic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, driven by both ethanol toxicity and nutritional deficiencies 1 2 3 22 29.

Diagnosis

Clinical history of significant alcohol use

Physical examination for signs of liver disease (jaundice, ascites, encephalopathy)

Laboratory tests: elevated liver enzymes (AST, ALT), hyperbilirubinemia, hypoalbuminemia, coagulopathy

Imaging: ultrasound, CT, MRI to assess liver morphology and detect complications

Liver biopsy (controversial; clinical diagnosis often sufficient 25)

Management

First-line treatments:

- Abstinence from alcohol: Essential for all stages 1 22 - Nutritional support: Addressing B-vitamin deficiencies, particularly folate, vitamins B6 and B12 5 7 28

Adjunctive treatments:

- Corticosteroids: Considered in severe alcoholic hepatitis with Maddrey's score ≥32 2 6 - Lecithin with vitamin-B complex: Potential benefit in immunomodulation and oxidative stress reduction 9 11 - Prophylactic antibiotics: Amoxicillin-clavulanate may reduce mortality in severe cases 2 (Evidence: Moderate)

Special Populations

Elderly: Higher mortality rates in ICU settings; careful monitoring and supportive care essential 6

Comorbidities: Systemic inflammation and multi-organ failure common in acute-on-chronic liver failure; intensive management required 4

Key Recommendations

Promote alcohol abstinence as the cornerstone of management (Evidence: Expert opinion) 1 22

Address nutritional deficiencies focusing on B-vitamins to support methionine metabolism (Evidence: Moderate) 5 7 28

Consider corticosteroid therapy in severe alcoholic hepatitis with appropriate clinical criteria (Evidence: Moderate) 2 6

Evaluate prophylactic antibiotics in severe cases to potentially reduce mortality (Evidence: Moderate) 2

References

1 Hu T, Liu CH, Zheng Y, Ji J, Zheng Y, He SK et al.. miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis. Expert review of gastroenterology & hepatology 2024. link 2 Louvet A, Labreuche J, Dao T, Thévenot T, Oberti F, Bureau C et al.. Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial. JAMA 2023. link 3 Wu J, Meng QH. Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease. World journal of gastroenterology 2020. link 4 Mehta G, Mookerjee RP, Sharma V, Jalan R. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure. Liver international : official journal of the International Association for the Study of the Liver 2015. link 5 Halsted CH. B-Vitamin dependent methionine metabolism and alcoholic liver disease. Clinical chemistry and laboratory medicine 2013. link 6 Kavli M, Strøm T, Carlsson M, Dahler-Eriksen B, Toft P. The outcome of critical illness in decompensated alcoholic liver cirrhosis. Acta anaesthesiologica Scandinavica 2012. link 7 Halsted CH, Medici V. Vitamin-dependent methionine metabolism and alcoholic liver disease. Advances in nutrition (Bethesda, Md.) 2011. link 8 Sofair AN, Barry V, Manos MM, Thomas A, Zaman A, Terrault NA et al.. The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. Journal of clinical gastroenterology 2010. link 9 Das SK, Gupta G, Rao DN, Vasudevan DM. Effect of lecithin with vitamin-B complex and tocopheryl acetate on long-term effect of ethanol induced immunomodulatory activities. Indian journal of experimental biology 2007. link 10 Mackle IJ, Swann DG, Cook B. One year outcome of intensive care patients with decompensated alcoholic liver disease. British journal of anaesthesia 2006. link 11 Das SK, Vasudevan DM. Modulation of lecithin activity by vitamin-B complex to treat long term consumption of ethanol induced oxidative stress in liver. Indian journal of experimental biology 2006. link 12 Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcoholism, clinical and experimental research 2005. link 13 Forrest EH. The impact of specialist management of jaundiced alcoholic liver disease patients. Scottish medical journal 2004. link 14 Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004. link 15 Rao RK, Seth A, Sheth P. Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. American journal of physiology. Gastrointestinal and liver physiology 2004. link 16 Bergheim I, Parlesak A, Dierks C, Bode JC, Bode C. Nutritional deficiencies in German middle-class male alcohol consumers: relation to dietary intake and severity of liver disease. European journal of clinical nutrition 2003. link 17 Lieber CS. Alcoholic liver injury: pathogenesis and therapy in 2001. Pathologie-biologie 2001. link00239-5) 18 Fujimoto M, Uemura M, Kojima H, Ishii Y, Ann T, Sakurai S et al.. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group. Alcoholism, clinical and experimental research 1999. link 19 Rácz I, Berecz M, Hársing J. Actinic granuloma in alcoholic liver disease. Cutis 1992. link 20 Nicholls R, de Jersey J, Worrall S, Wilce P. Modification of proteins and other biological molecules by acetaldehyde: adduct structure and functional significance. The International journal of biochemistry 1992. link90285-9) 21 Christoffersen P, Junge J. The spectrum of alcohol induced liver disease. Histological features. APMIS. Supplementum 1991. link 22 Lieber CS. Alcohol, liver, and nutrition. Journal of the American College of Nutrition 1991. link 23 Groover JR. Alcoholic liver disease. Emergency medicine clinics of North America 1990. link 24 de Cuenca-Moron B, Solis-Herruzo JA, Moreno D, Guijarro C, Gentil AA, Castellano G. Spontaneous bacterial peritonitis due to Yersinia enterocolitica in secondary alcoholic hemochromatosis. Journal of clinical gastroenterology 1989. link 25 Atterbury CE. Should we routinely perform liver biopsy in suspected alcoholic liver disease?. Journal of clinical gastroenterology 1988. link 26 Varju T, Lesch M, Adorján A. Hypertrophic osteoarthropathy associated with alcoholic liver disease without cirrhosis. Clinical and experimental rheumatology 1986. link 27 van de Wiel A, Schuurman HJ, van Riessen D, Haaijman JJ, Radl J, Delacroix DL et al.. Characteristics of IgA deposits in liver and skin of patients with liver disease. American journal of clinical pathology 1986. link 28 Majumdar SK, Shaw GK, O'Gorman P, Aps EJ, Offerman EL, Thomson AD. Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 1982. link 29 Mezey E. Alcoholic liver disease: roles of alcohol and malnutrition. The American journal of clinical nutrition 1980. link 30 Morgan MY. Alcohol and the liver. Journal of human nutrition 1979. link 31 Nenci I. Identification of actin-like proteins in alcoholic hyaline by immunofluorescence. Laboratory investigation; a journal of technical methods and pathology 1975. link 32 Baker H, Frank O, Zetterman RK, Rajan KS, ten Hove W, Leevy CM. Inability of chronic alcoholics with liver disease to use food as a source of folates, thiamin and vitamin B6. The American journal of clinical nutrition 1975. link

Acute alcoholic liver disease